Publikation: Emerging roles of tyrosine kinases in hepatic inflammatory diseases and therapeutic opportunities
Dateien
Datum
Autor:innen
Herausgeber:innen
ISSN der Zeitschrift
Electronic ISSN
ISBN
Bibliografische Daten
Verlag
Schriftenreihe
Auflagebezeichnung
DOI (zitierfähiger Link)
Internationale Patentnummer
Angaben zur Forschungsförderung
Projekt
Open Access-Veröffentlichung
Sammlungen
Core Facility der Universität Konstanz
Titel in einer weiteren Sprache
Publikationstyp
Publikationsstatus
Erschienen in
Zusammenfassung
Inflammation has been convicted of causing and worsening many liver diseases like acute liver failure, fibrosis, cirrhosis, fatty liver and liver cancer. Pattern recognition receptors (PRRs) like TLRs 4 and 9 localized on resident or recruited immune cells are well known cellular detectors of pathogen and damage-associated molecular patterns (PAMPs/DAMPs). Stimulation of these receptors generates the sterile and non-sterile inflammatory responses in the liver. When these responses are repeated, there will be a sustained liver injury that may progress to fibrosis and its outcomes. Crosstalk between inflammatory/fibrogenic-dependent streams and certain tyrosine kinases (TKs) has recently evolved in the context of hepatic diseases. Because of TKs increasing importance, their role should be elucidated to highlight effective approaches to manage the diverse liver disorders. This review will give a brief overview of types and functions of some TKs like BTK, JAKs, Syk, PI3K, Src and c-Abl, as well as receptors for TAM, PDGF, EGF, VEGF and HGF. It will then move to discuss the roles of these TKs in the regulation of the proinflammatory, fibrogenic and tumorigenic responses in the liver. Lastly, the therapeutic opportunities for targeting TKs in hepatic inflammatory disorders will be addressed. Overall, this review sheds light on the diverse TKs that have substantial roles in hepatic disorders and potential therapeutics modulating their activity.
Zusammenfassung in einer weiteren Sprache
Fachgebiet (DDC)
Schlagwörter
Konferenz
Rezension
Zitieren
ISO 690
SHAKER, Mohamed E., Hesham A. M. GOMAA, Mohamed A. ABDELGAWAD, Mohamed ELMESERY, Ahmed A. SHAABAN, Sara H. HAZEM, 2023. Emerging roles of tyrosine kinases in hepatic inflammatory diseases and therapeutic opportunities. In: International Immunopharmacology. Elsevier. 2023, 120, 110373. ISSN 1567-5769. eISSN 1878-1705. Available under: doi: 10.1016/j.intimp.2023.110373BibTex
@article{Shaker2023Emerg-67347, year={2023}, doi={10.1016/j.intimp.2023.110373}, title={Emerging roles of tyrosine kinases in hepatic inflammatory diseases and therapeutic opportunities}, volume={120}, issn={1567-5769}, journal={International Immunopharmacology}, author={Shaker, Mohamed E. and Gomaa, Hesham A. M. and Abdelgawad, Mohamed A. and Elmesery, Mohamed and Shaaban, Ahmed A. and Hazem, Sara H.}, note={Article Number: 110373} }
RDF
<rdf:RDF xmlns:dcterms="http://purl.org/dc/terms/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bibo="http://purl.org/ontology/bibo/" xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:void="http://rdfs.org/ns/void#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/67347"> <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/> <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2023-07-11T05:34:55Z</dc:date> <bibo:uri rdf:resource="https://kops.uni-konstanz.de/handle/123456789/67347"/> <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2023-07-11T05:34:55Z</dcterms:available> <dc:language>eng</dc:language> <dc:contributor>Hazem, Sara H.</dc:contributor> <dc:contributor>Gomaa, Hesham A. M.</dc:contributor> <dc:contributor>Abdelgawad, Mohamed A.</dc:contributor> <dc:contributor>Elmesery, Mohamed</dc:contributor> <dc:creator>Abdelgawad, Mohamed A.</dc:creator> <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/> <dc:contributor>Shaaban, Ahmed A.</dc:contributor> <dc:creator>Gomaa, Hesham A. M.</dc:creator> <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/> <dcterms:title>Emerging roles of tyrosine kinases in hepatic inflammatory diseases and therapeutic opportunities</dcterms:title> <dcterms:issued>2023</dcterms:issued> <dc:creator>Shaker, Mohamed E.</dc:creator> <dc:creator>Elmesery, Mohamed</dc:creator> <dc:creator>Shaaban, Ahmed A.</dc:creator> <dc:creator>Hazem, Sara H.</dc:creator> <dc:contributor>Shaker, Mohamed E.</dc:contributor> <foaf:homepage rdf:resource="http://localhost:8080/"/> <dcterms:abstract>Inflammation has been convicted of causing and worsening many liver diseases like acute liver failure, fibrosis, cirrhosis, fatty liver and liver cancer. Pattern recognition receptors (PRRs) like TLRs 4 and 9 localized on resident or recruited immune cells are well known cellular detectors of pathogen and damage-associated molecular patterns (PAMPs/DAMPs). Stimulation of these receptors generates the sterile and non-sterile inflammatory responses in the liver. When these responses are repeated, there will be a sustained liver injury that may progress to fibrosis and its outcomes. Crosstalk between inflammatory/fibrogenic-dependent streams and certain tyrosine kinases (TKs) has recently evolved in the context of hepatic diseases. Because of TKs increasing importance, their role should be elucidated to highlight effective approaches to manage the diverse liver disorders. This review will give a brief overview of types and functions of some TKs like BTK, JAKs, Syk, PI3K, Src and c-Abl, as well as receptors for TAM, PDGF, EGF, VEGF and HGF. It will then move to discuss the roles of these TKs in the regulation of the proinflammatory, fibrogenic and tumorigenic responses in the liver. Lastly, the therapeutic opportunities for targeting TKs in hepatic inflammatory disorders will be addressed. Overall, this review sheds light on the diverse TKs that have substantial roles in hepatic disorders and potential therapeutics modulating their activity.</dcterms:abstract> </rdf:Description> </rdf:RDF>